Bridging the Gap Between Global Innovation and the Croatian Market

Bringing a new medicine to market requires more than just a plan; it requires deep local insight and a proven track record.

With over 25 years of experience in the pharmaceutical industry, I founded my consultancy to ensure that innovative treatments reach the patients who need them most.

Let's get in touch

I partner with pharmaceutical companies in two strategic ways:

- Market Entry: Acting as the local bridge for international firms looking to establish a footprint and launch medicines in Croatia.

- Specialized Expertise: Providing high-level consultancy for companies already present in the region that require niche knowledge in complex therapeutic areas, such as Oncology.

My goal is to turn regulatory and market complexities into streamlined success for your portfolio.

My Services:

Strategic Market Entry & Pre-Launch

Market Entry Strategy: Tailored consultancy to navigate the Croatian regulatory and commercial landscape, ensuring a lean and effective launch plan.

Pre-Launch Orchestration: Expert design and execution of pre-launch milestones to build market readiness and clinical advocacy.

Gap Analysis: Identifying local market hurdles early to mitigate risk before capital investment.

Local Representation & Stakeholder Management

Health Authority Liaison: Acting as your local face and voice before healthcare administrations and regulatory bodies.

Stakeholder Engagement: Building and maintaining critical relationships with Key Opinion Leaders (KOLs), payers, and institutional decision-makers.

Commercialization & In-Licensing

Full-Cycle Commercialization: End-to-end support to maximize product reach, patient access, and commercial impact in Croatia.

In-Licensing Partnerships: Identifying and facilitating in-licensing opportunities for pharmaceutical products to establish a sustainable market footprint.

Distribution Strategy: Advising on local supply chain and distribution networks to ensure seamless product flow.

Oncology & High-Complexity Therapeutic Expertise

Oncology requires more than just a market entry plan; it requires a deep understanding of the clinical landscape and payer nuances. I provide specialized consultancy for oncology products, helping firms manage the intricacies of:

KOL Mapping: Identifying and engaging the specific clinical leaders in the Croatian oncology community.

Market Access: Navigating the reimbursement and hospital-tender complexities specific to high-cost cancer therapies.

Scientific Positioning: Ensuring your product’s clinical value is effectively communicated to local decision-makers.